Get started
iRadimed CorporationiRadimed CorporationiRadimed Corporation

iRadimed Corporation

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

IRMD chart


Full chart

IRMD upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪660.03 M‬ USD
Dividend yield (indicated)
1.15%
Price to earnings Ratio (TTM)
35.10
Basic EPS (TTM)
1.47 USD
Net income (FY)
‪17.19 M‬ USD
Revenue (FY)
‪65.56 M‬ USD
Shares float
‪7.99 M‬
Beta (1Y)
1.30

Employees


Employees (FY)
148
Change (1Y)
+25 +20.33%
Revenue / Employee (1Y)
‪442.99 K‬ USD
Net income / Employee (1Y)
‪116.17 K‬ USD

About iRadimed Corporation


Sector
Health Technology
Industry
Medical Specialties
CEO
Roger Susi
Website
iradimed.com
Headquarters
Winter Springs
Founded
1992
FIGI
BBG006NM92X2
IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

IRMD news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of IRMD is 52.08 USD — it has increased by 1.62% in the past 24 hours. Watch iRadimed Corporation stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange iRadimed Corporation stocks are traded under the ticker IRMD.
IRMD stock has fallen by −9.01% compared to the previous week, the month change is a 0.77% rise, over the last year iRadimed Corporation has showed a 20.28% increase.
We've gathered analysts' opinions on iRadimed Corporation future price: according to them, IRMD price has a max estimate of 60.00 USD and a min estimate of 60.00 USD. Watch IRMD chart and read a more detailed iRadimed Corporation stock forecast: see what analysts think of iRadimed Corporation and suggest that you do with its stocks.
IRMD reached its all-time high on Nov 11, 2024 with the price of 57.95 USD, and its all-time low was 6.26 USD and was reached on Sep 3, 2014. View more price dynamics on IRMD chart.
See other stocks reaching their highest and lowest prices.
IRMD stock is 2.29% volatile and has beta coefficient of 1.30. Track iRadimed Corporation stock price on the chart and check out the list of the most volatile stocks — is iRadimed Corporation there?
Today iRadimed Corporation has the market capitalization of ‪660.03 M‬, it has decreased by −7.57% over the last week.
Yes, you can track iRadimed Corporation financials in yearly and quarterly reports right on TradingView.
iRadimed Corporation is going to release the next earnings report on Feb 6, 2025. Keep track of upcoming events with our Earnings Calendar.
IRMD earnings for the last quarter are 0.43 USD per share, whereas the estimation was 0.41 USD resulting in a 6.17% surprise. The estimated earnings for the next quarter are 0.43 USD per share. See more details about iRadimed Corporation earnings.
iRadimed Corporation revenue for the last quarter amounts to ‪18.33 M‬ USD, despite the estimated figure of ‪18.15 M‬ USD. In the next quarter, revenue is expected to reach ‪18.94 M‬ USD.
IRMD net income for the last quarter is ‪5.05 M‬ USD, while the quarter before that showed ‪4.90 M‬ USD of net income which accounts for 3.03% change. Track more iRadimed Corporation financial stats to get the full picture.
Yes, IRMD dividends are paid quarterly. The last dividend per share was 0.15 USD. As of today, Dividend Yield (TTM)% is 0.86%. Tracking iRadimed Corporation dividends might help you take more informed decisions.
iRadimed Corporation dividend yield was 0.32% in 2023, and payout ratio reached 11.10%. The year before the numbers were 0.00% and 0.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 21, 2024, the company has 148.00 employees. See our rating of the largest employees — is iRadimed Corporation on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. iRadimed Corporation EBITDA is ‪22.15 M‬ USD, and current EBITDA margin is 31.73%. See more stats in iRadimed Corporation financial statements.
Like other stocks, IRMD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade iRadimed Corporation stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So iRadimed Corporation technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating iRadimed Corporation stock shows the strong buy signal. See more of iRadimed Corporation technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.